ASSET PURCHASE AGREEMENT by and between 14NER ONCOLOGY, INC. and MERRIMACK PHARMACEUTICALS, INC. Dated as of May 28, 2019Asset Purchase Agreement • May 30th, 2019 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 30th, 2019 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of May 28, 2019, by and between 14ner Oncology, Inc., a Delaware corporation (the “Buyer”), and Merrimack Pharmaceuticals, Inc., a Delaware corporation (the “Seller”).